Kangstem Biotech Co., Ltd. (KOSDAQ:217730)
1,712.00
-51.00 (-2.89%)
At close: Nov 16, 2026
Kangstem Biotech Market Cap
Kangstem Biotech has a market cap or net worth of 161.02 billion as of November 16, 2026. It is the 23,608th most valuable company in the world and the 910th biggest in South Korea. Its market cap has increased by 11.97% in one year.
Market Cap
161.02B
Enterprise Value
142.80B
Revenue
3.03B
Global Rank
Country Rank
#910 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 21, 2015, Kangstem Biotech's market cap has increased from 129.33B to 161.02B, an increase of 24.51%. That is a compound annual growth rate of 2.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 161.02B | -26.21% |
| Dec 30, 2025 | 218.21B | 92.71% |
| Dec 30, 2024 | 113.23B | -15.48% |
| Dec 28, 2023 | 133.97B | 21.98% |
| Dec 29, 2022 | 109.83B | -11.47% |
| Dec 30, 2021 | 124.06B | -36.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IMBiologics | 200.00B |
| IntoCell | 196.49B |
| HansBiomed | 179.12B |
| curacle co.,ltd. | 176.37B |
| Genome & Company | 164.74B |
| NIBEC | 146.31B |
| Y-Biologics | 134.77B |
| ISU Abxis | 131.09B |